Baird Starts Twist Bioscience (TWST) at Outperform

Baird analyst Catherine Ramsey Schulte initiates coverage on Twist Bioscience (NASDAQ: TWST) with a Outperform rating and a price target of $30.00.

For an analyst ratings summary and ratings history on Twist Bioscience click here. For more ratings news on Twist Bioscience click here.

Shares of Twist Bioscience closed at $25.99 yesterday.

You May Also Be Interested In

• Scorpion Capital says short Twist Biosciences
• Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
• Keefe, Bruyette & Woods Resumes Royal Bank of Canada (RY:CN) (RY) at Market Perform